Free Trial

Oncolytics Biotech (ONC) Insider Trading & Ownership

Oncolytics Biotech logo
C$1.37 -0.03 (-2.14%)
As of 08/1/2025 03:59 PM Eastern

Oncolytics Biotech (TSE:ONC) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.82%
Number Of
Insiders Buying
(Last 12 Months)
5
Amount Of
Insider Buying
(Last 12 Months)
C$178.19K
Number Of
Insiders Selling
(Last 12 Months)
0
Get ONC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Oncolytics Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ONC Insider Buying and Selling by Quarter

Oncolytics Biotech Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/17/2025Allison HagermanSenior OfficerBuy4,600C$1.71C$7,866.00
7/17/2025Thomas HeinemanSenior OfficerBuy15,000C$1.74C$26,098.50
7/16/2025Jared Ryan KellySenior OfficerBuy50,400C$1.63C$82,284.50
7/15/2025Andrew P. AromandoSenior OfficerBuy25,500C$1.62C$41,425.92
7/15/2025Kirk LookSenior OfficerBuy12,800C$1.60C$20,517.12
(Data available from 1/1/2013 forward)

ONC Insider Trading Activity - Frequently Asked Questions

The list of insiders at Oncolytics Biotech includes Allison Hagerman, Andrew P. Aromando, Jared Ryan Kelly, Kirk Look, and Thomas Heineman. Learn more on insiders at ONC.

3.82% of Oncolytics Biotech stock is owned by insiders. Learn more on ONC's insider holdings.

The following insiders have purchased ONC shares in the last 24 months: Allison Hagerman (C$7,866.00), Andrew P. Aromando (C$41,425.92), Jared Ryan Kelly (C$82,284.50), Kirk Look (C$20,517.12), and Thomas Heineman (C$26,098.50).

Insiders have purchased a total of 108,300 ONC shares in the last 24 months for a total of C$178,192.04 bought.

Oncolytics Biotech Key Executives

  • Dr. Matthew C. Coffey M.B.A.
    Ph.D., President, CEO & Director
  • Mr. Kirk J. Look C.A.
    CA, Chief Financial Officer
  • Dr. Thomas C. Heineman M.D.
    Ph.D., Chief Medical Officer
  • Ms. Allison Hagerman P.Eng.
    P.M.P., Vice President of Product Development
    1 recent trades
  • Ms. Amy Goodowitz Levin B.S.N.
    R.N., Vice President of Clinical Operations
  • Jon Patton
    Director of Investor Relations & Communication
  • Mr. John Mark Lievonen BBA
    C.M., FCA, LLD, MBA, Consultant


This page (TSE:ONC) was last updated on 8/3/2025 by MarketBeat.com Staff
From Our Partners